Benn, Marianne

Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women

Nordestgaard, B. G., Benn, M., Schnohr, P., & Tybjærg-Hansen, A. (2007) · JAMA

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 2,058

Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease

Varbo, A., Benn, M., Tybjærg-Hansen, A., Jørgensen, A. B., Frikke-Schmidt, R., & Nordestgaard, B. G. (2013) · Journal of the American College of Cardiology

Lipoproteins and Cardiovascular HealthGenetic Associations and Epidemiology

Cited by 1,115

The UK10K project identifies rare variants in health and disease

The UK10K Consortium, Writing group, Walter, K., Min, J. L., Huang, J., Crooks, L., Memari, Y., McCarthy, S., Perry, J. R. B., Xu, C., et al. (2015) · Nature

Genetic Associations and EpidemiologyGenomics and Rare Diseases

Cited by 1,040

Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation

Varbo, A., Benn, M., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2013) · Circulation

Lipoproteins and Cardiovascular HealthAtherosclerosis and Cardiovascular Diseases

Cited by 692

Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies: A Mendelian Randomization Analysis

Burgess, S., Ference, B. A., Staley, J. R., Freitag, D. F., Mason, A. M., Nielsen, S. F., Willeit, P., Young, R., Surendran, P., Karthikeyan, S., et al. (2018) · JAMA Cardiology

Lipoproteins and Cardiovascular HealthGenetic Associations and Epidemiology

Cited by 689

2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias

Mach, F., Koskinas, K. C., Roeters van Lennep, J. E., Tokgözoğlu, L., Badimon, L., Baigent, C., Benn, M., Binder, C. J., Catapano, A. L., De Backer, G. G., et al. (2025) · European Heart Journal

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 688

Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication

Benn, M., Watts, G. F., Tybjaerg-Hansen, A., & Nordestgaard, B. G. (2012) · The Journal of Clinical Endocrinology & Metabolism

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 632

Rare and low-frequency coding variants alter human adult height

Marouli, E., Graff, M., Medina-Gomez, C., Lo, K. S., Wood, A. R., Kjaer, T. R., Fine, R. S., Lu, Y., Schurmann, C., Highland, H. M., et al. (2017) · Nature

Genetic Associations and EpidemiologyGenetics and Physical Performance

Cited by 610

Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts

Palmer, T. M., Nordestgaard, B. G., Benn, M., Tybjaerg-Hansen, A., Davey Smith, G., Lawlor, D. A., & Timpson, N. J. (2013) · BMJ

Gout, Hyperuricemia, Uric AcidGenetic Associations and Epidemiology

Cited by 282

Remnant cholesterol as a cause of ischemic heart disease: Evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment

Varbo, A., Benn, M., & Nordestgaard, B. G. (2014) · Pharmacology & Therapeutics

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 251

Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society

Roeters van Lennep, J. E., Tokgözoğlu, L. S., Badimon, L., Dumanski, S. M., Gulati, M., Hess, C. N., Holven, K. B., Kavousi, M., Kayıkçıoğlu, M., Lutgens, E., et al. (2023) · European Heart Journal

Lipoproteins and Cardiovascular HealthSex and Gender in Healthcare

Cited by 229

Low LDL cholesterol,PCSK9 and HMGCR genetic variation, and risk of Alzheimer’s disease and Parkinson’s disease: Mendelian randomisation study

Benn, M., Nordestgaard, B. G., Frikke-Schmidt, R., & Tybjærg-Hansen, A. (2017) · BMJ

Lipoproteins and Cardiovascular HealthDementia and Cognitive Impairment Research

Cited by 178

PCSK9 R46L loss-of-function mutation reduces lipoprotein(a), LDL cholesterol, and risk of aortic valve stenosis

Langsted, A., Nordestgaard, B. G., Benn, M., Tybjærg-Hansen, A., & Kamstrup, P. R. (2016) · The Journal of Clinical Endocrinology & Metabolism

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 136

Nonfasting triglycerides, cholesterol, and ischemic stroke in the general population

Varbo, A., Nordestgaard, B. G., Tybjærg‐Hansen, A., Schnohr, P., Jensen, G. B., & Benn, M. (2011) · Annals of Neurology

Lipoproteins and Cardiovascular HealthAcute Ischemic Stroke Management

Cited by 122

Apolipoprotein B levels, APOB alleles, and risk of ischemic cardiovascular disease in the general population, a review

Benn, M. (2009) · Atherosclerosis

Lipoproteins and Cardiovascular HealthGenetic Associations and Epidemiology

Cited by 119

Antihypertensive treatment and risk of atrial fibrillation: a nationwide study

Marott, S. C. W., Nielsen, S. F., Benn, M., & Nordestgaard, B. G. (2014) · European Heart Journal

Atrial Fibrillation Management and OutcomesBlood Pressure and Hypertension Studies

Cited by 107

Impact of glucose level on micro- and macrovascular disease in the general population: a Mendelian randomization study

Emanuelsson, F., Marott, S., Tybjærg-Hansen, A., Nordestgaard, B. G., & Benn, M. (2020) · Diabetes Care

Genetic Associations and EpidemiologyDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 59

Low LDL cholesterol by PCSK9 variation reduces cardiovascular mortality

Benn, M., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2019) · Journal of the American College of Cardiology

Lipoproteins and Cardiovascular HealthGenetic Associations and Epidemiology

Cited by 51

Impact of high glucose levels and glucose lowering on risk of ischaemic stroke: a Mendelian randomisation study and meta-analysis

Benn, M., Emanuelsson, F., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2021) · Diabetologia

Acute Ischemic Stroke ManagementDiabetes Treatment and Management

Cited by 41